News | February 08, 2010

Philips Highlights Hybrid ORs, Cardiac Imaging, Testing at ACC

At the American College of Cardiology (ACC) 2010, Philips Healthcare will focus on the full spectrum of cardiology care – from diagnosis and treatment to disease management and home monitoring to enhance patient care. Philips is the imaging systems sponsor of the ACC’s Hybrid OR Suite exhibit, a combination cath lab and operating room.

Attendees can experience how Philips imaging equipment and solutions and its partnerships with leading OR equipment makers can help create an optimally designed hybrid.

New at ACC will be Cardiac Explorer, a package that helps in determining heart parameters from MR data into a comprehensive clinical report. It uses a task-guided approach where users are led step-by-step through successive tasks required to generate a clinical report. Cardiac analysis includes completely automated segmentation of the endo and epicardial boundaries, and a full report is generated with a detailed overview of global and regional heart function and wall motion parameters, including diastolic function.

The company will showcase the clinical advancements the Brilliance iCT, including new software. The newest program is a coronary plaque analysis application, which enables clinicians to gain a better understanding of the distribution and composition of plaque inside coronary vessels. This evaluation helps identify sites that are dangerous and which are small in size, but may become dangerous if not treated.

The PageWriter TC series of electrocardiographs (ECGs) combines easy operation with interpretations. The systems offer a suite of STEMI diagnostic aids, enabled by the advanced DXL ECG Algorithm, to help quickly identify when a patient requires immediate physician attention. When used with the TraceMasterVue ECG management system, the clinical user also can have immediate access to previous ECG records at the point of decision.

Announced in January 2010, Philips and bioMérieux have reached an agreement to jointly develop fully automated handheld diagnostic testing solutions for hospital use that can be deployed at the point-of-care. In critical-care settings, such as emergency departments, there is a persistent clinical need for diagnostic solutions that enable fast and accurate patient triage, such diagnosing acute coronary syndromes. The automated handheld testing devices that will be developed jointly by Philips and bioMérieux will be immunoassay-based and employ Philips’ new Magnotech biosensor platform. They are intended to assist clinicians in time-critical decision-making by reducing delays involved in laboratory-based testing.

From Philips Respironics, the Alice PDx Portable Recording System is a diagnostic recording device with advanced features intended for obstructive sleep apnea (OSA) diagnosis or assessment of cardio-respiratory sleep disorders. The device is convenient for patients who are uncomfortable with, or have limited access to, a sleep lab facility. The Good Study Indicator incorporated into the device helps clinicians determine the validity of the data that has been collected overnight. Remote testing and data verification both help clinicians avoid the costs associated with retesting.

The Philips Healthcare booth is 1343. Its hybrid OR suite will be located in booth 2744.

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
CDN to Integrate Advanced Cardiac Imaging Tools From DiA Imaging Analysis
Technology | August 10, 2017
August 10, 2017 — CDN recently announced a new partnership agreement with DiA Imaging Analysis Ltd., makers of next-g
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Overlay Init